Bautista, Ermenido F.

HRN: 25-06-11  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2024
CEFTRIAXONE 1G (VIAL)
05/19/2024
05/25/2024
IV
2g
Q24
Bowel Obstruction
Waiting Final Action 
05/19/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/19/2024
05/26/2024
IV
500mg
Q8hrs
Bowel Obstruction
Waiting Final Action 
05/22/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/22/2024
05/29/2024
IV
4.5g
Q6H
CMBO; S/P Exlap
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: